Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1983 Aug;49(4):673–683.

Chronic liver disease: the detection and characterization of circulating immune complexes.

S E Brown, M W Steward, L Viola, C R Howard, I M Murray-Lyon
PMCID: PMC1454316  PMID: 6307866

Abstract

Circulating immune complexes containing IgG, IgM and hepatitis B surface antigen (HBsAg) in sera from groups of patients with various liver diseases were detected by both the C1q and conglutinin solid phase assays. Elevated levels of antigen non-specific immune complexes were observed in sera from all groups and complexes containing IgG were present to a greater extent than were IgM-containing complexes. Higher levels of complexes were generally obtained using the conglutinin assay than the C1q assay and the two assays were shown to preferentially bind complexes of different size ranges and antigen-antibody ratios. Only sera from HBsAg-positive patients had complexes containing HBsAg, and although serum HBsAg titres and levels of HBsAg-containing complexes were correlated, the correlation coefficient was low. The mean levels of immune complexes and the frequency of positive sera varied between different disease categories, but there was little correlation between levels of the three types of complexes detected by the two tests. Assay of immune complexes in sequential serum samples from an individual patient revealed considerable variation in the levels of the three complex types, demonstrating that the measurement of complexes in single serum samples is of limited value in assessing the potential significance of circulating immune complexes in hepatitis B.

Full text

PDF
674

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrass C. K., Border W. A., Hepner G. Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol. 1980 May;40(2):292–298. [PMC free article] [PubMed] [Google Scholar]
  2. Alpers J. H., Steward M. W., Soothill J. F. Differences in immune elimination in inbred mice. The role of low affinity antibody. Clin Exp Immunol. 1972 Sep;12(1):121–132. [PMC free article] [PubMed] [Google Scholar]
  3. Anh-Tuan N., Novák E. Detection and quantitation of hepatitis-B surface antigen immune complexes (HBsAg-ICs) by an antigen-specific method. I. Detection and quantitation of in vitro prepared HBsAg-ICs. J Immunol Methods. 1980;33(3):293–300. doi: 10.1016/0022-1759(80)90216-1. [DOI] [PubMed] [Google Scholar]
  4. Anh-Tuan N., Novák E. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with hepatitis B and asymptomatic HBsAg carriers. Clin Exp Immunol. 1981 Feb;43(2):246–253. [PMC free article] [PubMed] [Google Scholar]
  5. Casali P., Bossus A., Carpentier N. A., Lambert P. H. Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests. Clin Exp Immunol. 1977 Aug;29(2):342–354. [PMC free article] [PubMed] [Google Scholar]
  6. D'Amelio R., Brighouse G., Barnet M., Lambert P. H. Antigen-specific detection of soluble immune complexes in conglutinin-binding assays. Clin Exp Immunol. 1981 Aug;45(2):283–289. [PMC free article] [PubMed] [Google Scholar]
  7. Devey M. E., Steward M. W. The induction of chronic antigen-antibody complex disease in selectively bred mice producing either high or low affinity antibody to protein antigens. Immunology. 1980 Oct;41(2):303–311. [PMC free article] [PubMed] [Google Scholar]
  8. Devey M. E., Taylor J., Steward M. W. Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays. J Immunol Methods. 1980;34(3):191–203. doi: 10.1016/0022-1759(80)90046-0. [DOI] [PubMed] [Google Scholar]
  9. Hay F. C., Nineham L. J., Roitt I. M. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol. 1976 Jun;24(3):396–400. [PMC free article] [PubMed] [Google Scholar]
  10. Jones V. E., Orlans E. Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review. J Immunol Methods. 1981;44(3):249–270. doi: 10.1016/0022-1759(81)90045-4. [DOI] [PubMed] [Google Scholar]
  11. Lambert P. H., Tribollet E., Celada A., Madalinski K., Frei P. C., Miescher P. A. Quantitation of immunoglobulin-associated HBs antigen in patients with acute and chronic hepatitis, in healthy carriers and in polyarteritis nodosa. J Clin Lab Immunol. 1980 Jan;3(1):1–8. [PubMed] [Google Scholar]
  12. Lawley T. J., James S. P., Jones E. A. Circulating immune complexes: their detection and potential significance in some hepatobiliary and intestinal diseases. Gastroenterology. 1980 Mar;78(3):626–641. [PubMed] [Google Scholar]
  13. Madaliński K., Bragiel I. HBsAg immune complexes in the course of infection with hepatitis B virus. Clin Exp Immunol. 1979 Jun;36(3):371–378. [PMC free article] [PubMed] [Google Scholar]
  14. Mannik M., Arend M. P., Hall A. P., Gilliland B. C. Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med. 1971 Apr 1;133(4):713–739. doi: 10.1084/jem.133.4.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McConahey P. J., Dixon F. J. A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966;29(2):185–189. doi: 10.1159/000229699. [DOI] [PubMed] [Google Scholar]
  16. Nielsen J. O., Dietrichson O., Juhl E. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. Lancet. 1974 Oct 19;2(7886):913–915. doi: 10.1016/s0140-6736(74)91127-1. [DOI] [PubMed] [Google Scholar]
  17. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pernice W., Sedlacek H. H. Antigen-specific detection of soluble immune complexes by a solid phase specific antibody system. J Immunol Methods. 1979;28(1-2):33–40. doi: 10.1016/0022-1759(79)90325-9. [DOI] [PubMed] [Google Scholar]
  19. Reed W. D., Eddleston A. L., Williams R. Immunopathology of viral hepatitis in man. Prog Med Virol. 1974;17(0):38–76. [PubMed] [Google Scholar]
  20. Rose L. M., Lambert P. H. The natural occurence of circulating idiotype--anti-idiotype complexes during a secondary immune response to phosphorylcholine. Clin Immunol Immunopathol. 1980 Mar;15(3):481–492. doi: 10.1016/0090-1229(80)90060-4. [DOI] [PubMed] [Google Scholar]
  21. Skelly J., Howard C. R., Zuckerman A. J. Analysis of hepatitis B surface antigen components solubilized with Triton X-100. J Gen Virol. 1979 Sep;44(3):679–689. doi: 10.1099/0022-1317-44-3-679. [DOI] [PubMed] [Google Scholar]
  22. Skelly J., Howard C. R., Zuckerman A. J. The labelling of galactose residues in hepatitis B surface antigen glycoprotein. J Gen Virol. 1978 Dec;41(3):447–457. doi: 10.1099/0022-1317-41-3-447. [DOI] [PubMed] [Google Scholar]
  23. Soothill J. F., Steward M. W. The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol. 1971 Aug;9(2):193–199. [PMC free article] [PubMed] [Google Scholar]
  24. Steward M. W. Chronic immune complex disease in mice: the role of antibody affinity. Clin Exp Immunol. 1979 Dec;38(3):414–423. [PMC free article] [PubMed] [Google Scholar]
  25. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  26. Thomas H. C., De Villiers D., Potter B., Hodgson H., Jain S., Jewell D. P., Sherlock S. Immune complexes in acute and chronic liver disease. Clin Exp Immunol. 1978 Feb;31(2):150–157. [PMC free article] [PubMed] [Google Scholar]
  27. Thomas H. C., McSween R. N., White R. G. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet. 1973 Jun 9;1(7815):1288–1291. doi: 10.1016/s0140-6736(73)91300-7. [DOI] [PubMed] [Google Scholar]
  28. Wands J. R., Zurawski V. R., Jr High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology. 1981 Feb;80(2):225–232. [PubMed] [Google Scholar]
  29. Yonemasu K., Stroud R. M. Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol. 1971 Feb;106(2):304–313. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES